SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation around potential rescheduling of marijuana following reports of a planned executive order. The community is discussing the possibility of a major uptrend, potential short squeezes, and analysts updating their target prices. Some traders express caution, pointing to reverse splits and past disappointments.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom ($AVGO) is trending as investors digest the company's earnings report and forward guidance, with community sentiment split between bullish expectations for new ATHs and concerns about potential profit-taking. Discussions revolve around the impact of AI chip revenue and gross margins on the stock's valuation. Analyst target price upgrades are anticipated, adding to the bullish outlook for some traders.

Mawson Infrastructure Group, Inc. engages in the provision of digital asset infrastructure services. The company was founded on February 10, 2012 and is headquartered in Midland, PA.

Mawson Infrastructure Group Inc

MIGI is trending due to a volatile trading day, with community members discussing a potential pump and dump scheme following a recent reverse split and subsequent offering. The stock's price experienced a significant surge and then a sharp decline, leading to debates about the company's fundamentals and market manipulation. Traders are actively speculating on whether MIGI can regain compliance with listing requirements and if further dilution is expected.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending as investors discuss the company's recent Q3 earnings, which included revenue growth and raised guidance, alongside the unexpected announcement of the CEO's departure in 2026. The community is actively debating the impact of these factors, with some anticipating analyst upgrades and a potential rally, while others express concerns about the future direction of the company amid leadership transition. A significant share buyback program has also fueled bullish sentiment, signaling confidence in Lululemon's trajectory.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as it showcases its in-house autonomy and AI technology at its first-ever Autonomy and AI Day, with community members discussing the potential impact of new AI-driven features and hardware on the company's future. Investors are weighing Rivian's strategy to develop its own chips and compete with Tesla's autonomous driving capabilities, while some express concerns about the timeline for implementation and the capital expenditure required. There are mixed opinions about the stock's potential, with some anticipating a significant rise and others remain cautious given the company's current financial position.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is trending as investors await key data and FDA feedback, with anticipation building around potential outcomes for Pemvidutide in MASH and obesity. Bullish community members express confidence in the science and potential buyout scenarios, while bears highlight concerns about trial results and data interpretation. The discussion also includes speculation around competitor data, potential partnership deals, and upcoming announcements.

AXIL Brands, Inc. engages in the manufacture, market, sale and distribution of hearing and audio enhancement, and protection products. It operates through the Hearing Enhancement and Protection, and Hair Care and Skin Care segments. The Hearing Enhancement and Protection segment includes ear buds, earmuffs, ear plugs, outdoor speakers, and ear care items. The Hair Care and Skin Care segment focuses on expanding its business-to-business salon sales through its network of domestic and international distributors. The company was founded on May 21, 2015 and is headquartered in Beverly Hills, CA.

AXIL Brands Inc.

AXIL Brands is trending due to a thin-float technical breakout, attracting momentum traders, with the community actively discussing overnight price action and potential for further gains. Community members are also pointing to a recent distribution agreement with Walmart as a longer-term catalyst. Traders are closely watching for offering news.

The GEO Group, Inc. engages in the design, financing, development, and support services for secure facilities, processing centers, and community re-entry facilities. It operates through the following segments: U.S. Secure, Electronic Monitoring and Supervision, Reentry, and International Services. The U.S. Secure Services segment encompasses the United States-based public-private partnership corrections and detention business. The Electronic Monitoring and Supervision Services segment conducts its services in the U.S. The Reentry Services Segment consists of various community-based and reentry services. The International Services segment consists of public-private partnership secure services operations in Australia and South Africa. The company was founded by George C. Zoley in 1984 and is headquartered in Boca Raton, FL.

Geo Group, Inc.

GEO Group is trending amid discussions around immigration enforcement, detention facilities, and the potential impact of government policies. Community perspectives are sharply divided, with some anticipating gains from increased ICE activity and others expressing ethical concerns and criticizing the company's business practices. The conversation also involves potential contract opportunities and the company's financial health.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences ($GLSI) is trending due to anticipation surrounding potential news related to its breast cancer treatment, with speculation focused on the SABCS conference. The community is exhibiting FOMO based on hints of positive data, and some believe shorts may be covering their positions. GLSI is seen as a promising healthcare stock, particularly for women, given its potential for high efficacy.

Frontdoor, Inc. engages in the provision of home service plans. Its home service plans cover the repair or replacement of major home’s systems and appliances. The firm’s service focuses on water heaters, garbage disposals, doorbells, smoke detectors, ceiling fans, central vacuums, refrigerators, dishwashers and trash compactors. Its brands include American Home Shield, HSA, OneGuard and Landmark. The company was founded on January 2, 2018, and is headquartered in Memphis, TN.

Frontdoor Inc.

$FTDR is trending as traders discuss recent trade alerts and potential bullish trends, while noting overbought conditions based on RSI. The community is also evaluating the stock's position relative to its moving averages and key resistance levels like the 60-day high. Overall sentiment appears mixed, balancing short-term profit-taking with longer-term growth potential in the home services sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

D. Boral Capital Reiterates "Buy" Rating for ImmunityBio (NASDAQ:IBRX)

D. Boral Capital reissued a "buy" rating and set a $24.00 price objective on shares of ImmunityBio in a research note on Thursday...

ImmunityBio (NASDAQ:IBRX) Sees Large Volume Increase - Still a Buy?

ImmunityBio (NASDAQ:IBRX) Sees Unusually-High Trading Volume - What's Next...

ImmunityBio (NASDAQ:IBRX) Shares Gap Up - Here's Why

ImmunityBio (NASDAQ:IBRX) Shares Gap Up - What's Next...

AlphaCore Capital LLC Takes $7.85 Million Position in ImmunityBio, Inc. $IBRX

AlphaCore Capital LLC purchased a new position in shares of ImmunityBio, Inc. (NASDAQ:IBRX - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and...

A Fresh $16 Million Bet on ImmunityBio: What Investors Should Know

Key PointsBought 6,565,709 shares of ImmunityBio, an increase of $16.15 million in position value...

ImmunityBio (NASDAQ:IBRX) Receives "Buy" Rating from D. Boral Capital

D. Boral Capital restated a "buy" rating and set a $24.00 target price on shares of ImmunityBio in a research report on Thursday...

New Survey Reveals Non-Muscle Invasive Bladder Cancer Patients Seek More Care Conversations

A new U.S. survey conducted by The Harris Poll on behalf of ImmunityBio, Inc. (NASDAQ: IBRX) reveals that many people living with non-muscle invasive bladder cancer (NMIBC) feel left out of critical...

Analysts Set Expectations for ImmunityBio FY2025 Earnings

ImmunityBio, Inc. (NASDAQ:IBRX - Free Report) - Equities research analysts at HC Wainwright increased their FY2025 earnings estimates for shares of ImmunityBio in a report released on Wednesday...

HC Wainwright Increases Earnings Estimates for ImmunityBio

ImmunityBio, Inc. (NASDAQ:IBRX - Free Report) - Investment analysts at HC Wainwright lifted their FY2029 earnings per share (EPS) estimates for shares of ImmunityBio in a research report issued to...

ImmunityBio (NASDAQ:IBRX) Earns "Buy" Rating from D. Boral Capital

D. Boral Capital reissued a "buy" rating and set a $24.00 price objective on shares of ImmunityBio in a research note on Wednesday...

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

Bullish: S&P grinds higher

Choppy but up: buy dips

Sideways: fade the move

Bearish: this rally falls off

The Federal Reserve just announced a 0.25 percentage point interest rate cut at its December 10, 2025 meeting.​ Share your outlook on how the latest Federal Reserve interest rate cut will impact stocks and the S&P 500 over the next month.

How do you think today’s Fed rate cut impacts stocks over the next month?

Current Price	$2.19
Prev Close	$2.30
Open	$2.30
Dividend Yield	0.00%
50-Day Moving Average	$2.30
Beta	2.09
Avg. Volume	9.71M
PE Ratio	-5.21

52-Week High	$4.27
52-Week Low	$1.83
Market Capitalization	$2.27B
EPS (Annual)	-$0.6189
Price to Book	-4.11
Revenue Per Employee	$21,683.82
Enterprise Value/EBITDA	N/A

IBRX
ImmunityBio Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IBRX News

IBRXImmunityBio Inc